The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine

Biochemical and immunological evaluation of recombinant CS6-derived subunit enterotoxigenic Escherichia coli vaccine candidates

(2019) Steven T. Poole et al.   INFECTION AND IMMUNITY

Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016

(2018) Ibrahim A Khalil et al.   LANCET INFECTIOUS DISEASES

The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT

(2018) John D. Clements et al.   mSphere

Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems

(2017) Prosper N. Boyaka   JOURNAL OF IMMUNOLOGY

Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial

(2017) Stephen J. Savarino et al.   JOURNAL OF INFECTIOUS DISEASES

Modes of Action for Mucosal Vaccine Adjuvants

(2017) Taiki Aoshi   VIRAL IMMUNOLOGY

Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study

(2016) Catherine A. Cosgrove et al.   PLoS One

Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates

(2016) Stephanie A. Sincock et al.   VACCINE

Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice

(2016) Wayne Paes et al.   VACCINE

Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen

(2016) Susan L. Baldwin et al.   VACCINE

A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations

(2016) Neal Van Hoeven et al.   PLoS One

Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy

(2015) Mark T. Orr et al.   VACCINE

Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

(2014) David J DiLillo et al.   NATURE MEDICINE

Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination

(2013) Mirte Scherpenisse et al.   Human Vaccines & Immunotherapeutics

A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)

(2011) Chad K. Porter et al.   VACCINE

A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression

(2011) S.D. Isidean et al.   VACCINE

A requirement for FcγR in antibody-mediated bacterial toxin neutralization

(2010) Nareen Abboud et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Molecular mechanisms of enterotoxigenic Escherichia coli infection

(2009) James M. Fleckenstein et al.   MICROBES AND INFECTION

Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

(2009) David J. M. Lewis et al.   PLoS One